Ignite Creation Date:
2024-05-06 @ 10:03 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03155009
Status:
COMPLETED
Last Update Posted:
2020-02-10
First Post:
2017-05-11
Brief Title:
A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase ALK-Rearranged Non-Small Cell Lung Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-10
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-11
First Submit QC Date:
May 15 2017
Study First Post Date:
2017-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-07
Last Update Post Date:
2020-02-10
Last Update Post Date Type:
ACTUAL